Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Combination of Levobupivacaine and Lidocaine for Paravertebral Block in Breast Cancer Patients Undergoing Quadrantectomy Causes Greater Hemodynamic Oscillations Than Levobupivacaine Alone

NCT02004834 is registered in ClinicalTrials.gov with University Hospital Dubrava as lead sponsor.

NCT NCT02004834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02004834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Combination of Levobupivacaine and Lidocaine for Paravertebral Block in Breast Cancer Patients Undergoing Quadrantectomy Causes Greater Hemodynamic Oscillations Than Levobupivacaine Alone
Lead sponsor
University Hospital Dubrava
Phase
Phase 4
Overall status
Active, not recruiting
Start date
August 31, 2013
Completion date
October 31, 2029
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bradycardia, breast tumors, hypotension